Federal Court of Australia
Federal Court of Australia
Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd (No 4) [2021] FCA 416 File numbers: NSD 121 of 2012 NSD 837 of 2015
Judgment of: YATES J
Date of judgment: 27 April 2021
Catchwords: PRACTICE AND PROCEDURE – application for additional discovery
Legislation: National Health Act 1953 (Cth) s 99ACB Federal Court Rules 2011 (Cth) rr 20.11, 20.15 Federal Court of Australia Act 1976 (Cth) s 37M
Cases cited: Benjoy Berry v CCL Secure Pty Ltd [2020] HCA 27; 381 ALR 427 Malec v JC Hutton Pty Ltd [1990] HCA 20; 169 CLR 638 Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd [2012] FCA 239 Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd [2019] FCA 230 Sellars v Adelaide Petroleum NL [1994] HCA 4; 179 CLR 332 Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth [2018] FCA 1556; 136 IPR 8
Division: General Division
Registry: New South Wales
National Practice Area: Intellectual Property
Sub-area: Patents and associated Statutes
Number of paragraphs: 64
Date of hearing: 8 March 2021
Counsel for the Applicants: Mr J Hutton
Solicitors for the Applicants: Jones Day
Counsel for the Respondents: Mr P Knowles
Solicitors for the Respondents: Corrs Chambers Westgarth
ORDERS NSD 121 of 2012
BETWEEN: OTSUKA PHARMACEUTICAL CO., LTD First Applicant/First Appellant
BRISTOL-MYERS SQUIBB COMPANY Second Applicant/Second Appellant
We try to embed the page this law was scraped from. If the site blocks framing, you still get the link and a local excerpt.
Last checked with source on —
Checking whether the official page can be embedded…
Plain-English simplify of this law: a short summary, key points, and both sides of the argument. Generated on first view via Replicate, then cached. Vote on what helps your study.
No study brief is cached for this law yet. Sign up to generate a plain-English brief.
Sign up to generate